Calendar Ampliphi Biosciences Corp Nyse
Equities
APHB
US03211P2020
Biotechnology & Medical Research
Upcoming events on Ampliphi Biosciences Corp
Past events on Ampliphi Biosciences Corp
2024-11-19 01:15 pm | Phage Futures Congress |
2024-11-13 04:05 pm | Q3 2024 Earnings Release |
2024-09-11 08:00 am | H.C. Wainwright Global Investment Conference |
2024-08-27 10:00 am | Military Health System Research Symposium |
2024-08-13 04:05 pm | Q2 2024 Earnings Release |
2024-07-17 09:20 pm | Viruses of Microbes Conference |
2024-06-11 | Annual General Meeting |
2024-05-07 04:01 pm | Q1 2024 Earnings Release |
2024-03-21 04:05 pm | Q4 2023 Earnings Release |
2024-02-28 12:00 pm | Bacteriophage Therapy Summit |
2023-11-14 04:00 pm | Q3 2023 Earnings Release |
2023-11-03 05:00 pm | North American Cystic Fibrosis Conference ( |
2023-10-25 09:10 am | Phage Futures: Global Digital Summit |
2023-09-26 02:45 pm | Cantor Global Healthcare Conference |
2023-09-13 | Annual General Meeting |
2023-08-14 07:00 am | Q2 2023 Earnings Release |
2023-06-02 04:50 pm | World Targeting Phage Therapy Conference |
2023-05-11 04:05 pm | Q1 2023 Earnings Release |
2023-03-16 04:10 pm | Q4 2022 Earnings Release |
2022-11-30 10:00 am | H.C. Wainwright Investor Conference |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 4,47 4,46 0.37% | 5,51 6,13 -10.11% | 4,53 3,87 17.01% | 5,50 | 5,50 |
EBITDA Million USD | Released Forecast Spread | -22,7 -26,3 13.87% | -36,1 -35,5 -1.56% | -39,9 -42,5 6.08% | -44,1 | -50,6 |
EBIT Million USD | Released Forecast Spread | -23,8 -24,9 4.17% | -36,9 -37,4 1.33% | -40,9 -44,9 8.85% | -44,1 | -50,6 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -23,2 -24,2 4.51% | -36,9 -36,6 -0.91% | -69,0 -62,0 -11.39% | -34,8 | -68,6 |
Net income Million USD | Released Forecast Spread | -23,2 -24,2 4.51% | -36,9 -36,6 -0.91% | -69,0 -62,0 -11.39% | -34,8 | -68,6 |
EPS USD | Released Forecast Spread | -0,96 -1,01 4.95% | -1,08 -1,07 -1.41% | -1,91 -1,71 -12.02% | -0,95 | -1,70 |
Announcement Date | 17/03/22 | 16/03/23 | 21/03/24 | - |
Quarterly results
Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,80 1,78 -55.26% | 0,98 1,81 -45.84% | 1,23 0,95 28.34% | 1,53 0,86 77.67% | 0,97 1,14 -14.93% | 0,00 1,14 - | 2,97 0,90 230.33% | 1,56 |
EBITDA Million USD | Released Forecast Spread | -11,1 -10,4 -6.88% | -9,40 -11,5 18.25% | -10,1 -11,6 12.8% | -9,29 -11,2 17.09% | -9,91 -10,2 2.83% | -11,6 -10,9 -6.41% | -9,44 -12,3 23.23% | -12,2 |
EBIT Million USD | Released Forecast Spread | -11,3 -12,9 12.36% | -9,63 -14,4 32.92% | -10,3 -10,5 1.94% | -9,58 -11,5 16.37% | -10,2 -10,9 6.14% | -11,9 -11,4 -4.22% | ||
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -14,5 -11,5 -25.53% | -3,55 -13,4 73.57% | -31,2 -11,3 -175.6% | -19,8 -12,8 -55.24% | -25,0 -11,2 -123.48% | 8,99 -16,0 156.18% | -5,48 -10,6 48.29% | -13,3 |
Net income Million USD | Released Forecast Spread | -14,5 -11,5 -25.53% | -3,55 -13,4 73.57% | -31,2 -11,3 -175.6% | -19,8 -12,8 -55.24% | -25,0 -11,2 -123.48% | 8,99 -16,0 156.18% | -5,48 -10,6 48.29% | -13,3 |
EPS USD | Released Forecast Spread | -0,40 -0,32 -25% | -0,10 -0,38 73.33% | -0,86 -0,31 -177.42% | -0,55 -0,35 -57.14% | -0,69 -0,31 -122.58% | 0,25 -0,44 156.82% | -0,15 -0,28 46.43% | -0,35 |
Announcement Date | 11/05/23 | 14/08/23 | 14/11/23 | 21/03/24 | 07/05/24 | 13/08/24 | 13/11/24 | - |
2025-02-19 08:00 am | KRYSTAL BIOTECH, INC.: Q4 2024 Earnings Release |
2025-02-19 | ARDELYX, INC.: Q4 2024 Earnings Release |
2025-02-19 | KURA ONCOLOGY, INC.: Q4 2024 Earnings Release (Projected) |
2025-02-19 | EDGEWISE THERAPEUTICS, INC.: Q4 2024 Earnings Release (Projected) |
2025-02-19 | Y-MABS THERAPEUTICS, INC.: Q4 2024 Earnings Release (Projected) |
2025-02-19 | CYTOKINETICS, INCORPORATED: Q4 2024 Earnings Release (Projected) |
2025-02-19 | INSMED INCORPORATED: Q4 2024 Earnings Release |
2025-02-19 | DYNAVAX TECHNOLOGIES CORPORATION: Q4 2024 Earnings Release |
2025-02-20 01:00 am | ZEALAND PHARMA A/S: Q4 2024 Earnings Release |
2025-02-20 06:30 am | SPRINGWORKS THERAPEUTICS, INC.: Q4 2024 Earnings Release |
Past sector events for Ampliphi Biosciences Corp
2025-02-13 06:31 am | AGIOS PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
2025-02-12 | ULTRAGENYX PHARMACEUTICAL INC.: Q4 2024 Earnings Release |
2025-02-12 | PROTHENA CORPORATION PLC: Q4 2024 Earnings Release (Projected) |
2025-02-12 | PEPTIDREAM INC.: Q4 2024 Earnings Release |
2025-02-12 04:01 pm | ASCENDIS PHARMA A/S: Q4 2024 Earnings Release |
2025-02-12 11:01 am | GENMAB A/S: Q4 2024 Earnings Release |
2025-02-12 07:30 am | ANAVEX LIFE SCIENCES CORP.: Q1 2025 Earnings Release |
2025-02-11 04:05 pm | EXELIXIS, INC.: Q4 2024 Earnings Release |
2025-02-11 07:00 am | ARVINAS, INC.: Q4 2024 Earnings Release |
2025-02-10 04:01 pm | ARROWHEAD PHARMACEUTICALS, INC.: Q1 2025 Earnings Release |